119th Congress
S. 4327
Securing America’s Drug Supply from Communist China Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Tom Cotton(R-AR)
- Introduced
- Apr 16, 2026
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (1)
Added later (1)
- Jim Banks (R-IN) · Aug 4, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Latest action(Apr 16, 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 16, 2026 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Apr 16, 2026
Introduced in Senate